<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <article-meta>
      <title-group>
        <article-title>A study of thyroid lesions using fine needle aspiration cytology technique</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="person">
          <name>
            <given-names>Dr.Avvaru Arjun Kumar</given-names>
          </name>
          <email>arjun2mbbs@gmail.com</email>
          <xref ref-type="aff" rid="aff-1"/>
        </contrib>
      </contrib-group>
      <aff id="aff-1">
        <institution>Assistant professor, Department of pathology, Rajiv Gandhi Institute of medical sciences, Kadapa</institution>
        <country>India</country>
      </aff>
      <history>
        <date date-type="received" iso-8601-date="2020-08-09">
          <day>09</day>
          <month>08</month>
          <year>2020</year>
        </date>
        <date data-type="published" iso-8601-date="2020-08-09">
          <day>09</day>
          <month>08</month>
          <year>2020</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <fig>
      <graphic mimetype="image" mime-subtype="jpeg" xlink:href="image1.jpeg"/>
    </fig>
    <p>
      <bold>www.ijamscr.com</bold>
    </p>
    <sec id="sec-1">
      <title>A study of thyroid lesions using fine needle aspiration cytology technique</title>
      <sec id="sec-1_1">
        <title>Dr.K.Sridhar Reddy<sup>1</sup>, Dr.A.Arjun Kumar<sup>2*</sup>, Dr.P.venkata Ramana<sup>3</sup>, S.Susmitha<sup>4</sup>, SK.Reshma<sup>4</sup><sub>,</sub>S.M.D. Yaseen<sup>4</sup></title>
        <p>
          <bold>
            <italic>
              <sup>1</sup>
            </italic>
          </bold>
          <italic>Assistant professor, Department of pathology, Rajiv Gandhi Institute of medical sciences, Kadapa</italic>
        </p>
        <p>
          <italic>
            <sup>2</sup>
          </italic>
          <italic>Assistant professor, Department of medicine, Rajiv Gandhi Institute of medical sciences, Kadapa</italic>
        </p>
        <p>
          <italic>
            <sup>3</sup>
          </italic>
          <italic>Assistant professor, Department of pharmacy practice, P.Rami </italic>
          <italic>reddy memorial college of pharmacy, Kadapa</italic>
        </p>
        <p>
          <italic>
            <sup>4</sup>
          </italic>
          <italic>Pharm-D Interns, Department of pharmacy practice, P.Rami reddy memorial college of pharmacy, Kadapa</italic>
        </p>
        <p>
          <bold>*Corresponding Author: </bold>
          <bold>Dr.Avvaru Arjun Kumar</bold>
        </p>
        <p>
          <bold>Email id: arjun2mbbs@gmail.com</bold>
        </p>
        <sec id="sec-1_1_1">
          <title>ABSTRACT</title>
          <sec id="sec-1_1_1_1">
            <title>Background</title>
            <p>Thyroid swellings are very common and can occur in various clinical settings and in various age groups. The modalities of treatment differ in different conditions. Some require therapeutic management and some others surgery. FNAC was proved to be the single most sensitive investigation in   differentiating neoplastic from non- neoplastic conditions, and benign from malignant conditions. At present this procedure is utilized extensively in diagnosing the condition and planning for surgery in necessary cases thus decreasing the unnecessary surgeries</p>
          </sec>
          <sec id="sec-1_1_1_2">
            <title>Objective(s)</title>
            <p>To prove the importance of FNAC as the first line diagnostic procedure for the evaluation of goiter. To study the scope of FNAC in differentiating neoplastic from non neoplastic lesion and its role as a diagnostic tool in picking up unsuspected malignancies and metastatic malignancies. </p>
          </sec>
          <sec id="sec-1_1_1_3">
            <title>Methods</title>
            <p>This study was conducted in the department of Pathology, on patients with thyroid swellings who attended the Medical, Surgical &amp; ENT OPs. FNAC  full clinical  examination of the patient was done  and  data like  present,  past and  personal  history  of  the patient  along  with  laboratory investigations  including  thyroid  profile  and  ultrasound  reports  were  collected. FNAC was done as an outpatient procedure.</p>
          </sec>
          <sec id="sec-1_1_1_4">
            <title>Results</title>
            <p>Out of the 330 cases diagnosed, majority were non neoplastic lesions (276) neoplastic were (54). Nodular goiter was found to be the commonest among all the lesions with 106 cases [32%] showing high prevalence between 21-30yrs and a male to female ratio of 1:8.7</p>
          </sec>
          <sec id="sec-1_1_1_5">
            <title>Conclusion</title>
            <p>FNAC has been found to be a most valuable, economized, safe and simple diagnostic procedure in the evaluation of thyroid swellings.</p>
            <p>Keywords:Thyroid lesions, fine needle aspiration cytology, malignancy, non malignancy.  </p>
          </sec>
        </sec>
        <sec id="sec-1_1_2"/>
        <sec id="sec-1_1_3">
          <title>INTRODUCTION</title>
          <p>Fine needle aspiration cytology method for studying the thyroid was first developed in Sweden in the Radium Helmet hospital of Stockholm during 1950.Martin &amp; Ellis of the memorial hospital for cancer reported its use even earlier in 1930. [1, 2, 3] At present FNAC of the thyroid is considered by many as first line procedure and it is fully accepted in the diagnostic work up of patients in conjunction with traditional methods.[4,5] FNAC is widely accepted as the most accurate, non-invasive, sensitive, specific and cost effective diagnostic procedure in the assessment of thyroid nodules and helps to select people pre operatively for surgery.[6,7] The main purpose of FNAC thyroid is to distinguish patients with malignant nodules and those with benign nodules.  It is the procedure of choice in the initial screening of thyroid nodules and it can be repeated as many times as necessary due to the minimal invasiveness and low morbidity. [8, 9]With FNAC, the number of thyroidectomise has been halved whereas the incidence of malignant lesions has doubled which indicates that it is possible to diagnose even the latent and occult malignancies. The consequences of this conservative methodology are yet to be evaluated. Definitely there is a chance of missing a co-existing lesion.[10,11]FNA is also indicated in the evaluation of goiter and in follow up of individuals who were exposed to irradiation of head and neck.[12] FNA is also useful as a therapeutic procedure for drainage of cystic lesions. Principal function of the thyroid gland is to act as a catalyst-of the nature of the spark for the maintenance of oxidative metabolism in most tissues.[13,14,15] It is also necessary for normal growth and maturation and tissue differentiation. The active circulating hormones of the thyroid gland are Tri-iodothyronin [T3] and Thyroxine [T4]. [16] The FNA smears show Follicular epithelial cells, Colloid, ` C’ Cells, Cartilage, Tracheal epithelium and sometimes fragments of skeletal muscle. The cytological appearance of normal thyroid gland varies with age and functional state.[17] Aspirations of normal thyroid yield little blood stained material Smears contain few Follicular cells and scant colloid with Follicular cells dispersed or in small clusters. Categorizing the diseases of the thyroid is of great importance because some lesions require medical management, such as thyrotoxicosis, hypothyroidism and diffuse or focal enlargement of thyroid due to thyroiditis and other lesions need surgical intervention such as neoplasms and   Nodular goiters causing compression. Follicular epithelial cells are fragile and the epithelial cells may vary in size from low cubical or flat to high columnar, the height and the configuration of the thyroid Follicular cells reflect to some extent the functional activity.[18] Bare nuclei of the Follicular cells that are similar in size &amp; shape as lymphocytes are common. Small nucleoli may be evident. Cytoplasm stains pale blue. Rarely follicles may be recovered. Colloid stains blue to purple and forms a thin membrane like coat, often with folds and cracks. ‘C’ cells resemble Medullary Carcinoma cells that are difficult to find in thyroid smears without resorting to immuno staining for calcitonin. The finding of ‘C’cell may indicate significant c cell hyperplasia. [19, 20]</p>
          <p><bold>Table 1. Major types of thyroid hyperplastic disorders</bold>. [21]</p>
          <table-wrap>
            <table>
              <tr>
                <td colspan="4">
                  <bold>Major types of thyroid hyperplastic </bold>
                  <bold>disorders.</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Name </bold>
                </td>
                <td>
                  <bold>Mechanism</bold>
                </td>
                <td>
                  <bold>Pathology</bold>
                </td>
                <td>
                  <bold>Functional status</bold>
                </td>
              </tr>
              <tr>
                <td>Dyshormonogenetic Goiter</td>
                <td>Genetically determined error in thyroid  hormone metabolism</td>
                <td>Nodular or less frequently diffuse hyperplasia.</td>
                <td>Hypothyroid</td>
              </tr>
              <tr>
                <td>Graves disease</td>
                <td>Auto immune</td>
                <td>Diffuse hyperplasia.</td>
                <td>Hyperthyroid</td>
              </tr>
              <tr>
                <td>Nodular hyperplasia-endemic goiter</td>
                <td>Iodine deficiency</td>
                <td>Nodular hyperplasia proceeded by a transient phase of diffuse hyperplasia.</td>
                <td>Usually euthyroid sometimes hypothyroid</td>
              </tr>
              <tr>
                <td>Sporadic goiter</td>
                <td>Unknown</td>
                <td>Nodular hyperplasia</td>
                <td>Usually euthyroid  sometimes hyperthyroid or hypothyroid.</td>
              </tr>
            </table>
          </table-wrap>
          <sec id="sec-1_1_3_1"/>
          <sec id="sec-1_1_3_2">
            <title>Neoplastic lesions</title>
            <p>The neoplastic lesions were divided on the basis of direction of dedifferentiatoin</p>
          </sec>
          <sec id="sec-1_1_3_3">
            <title>Tumours of thyroid Follicular or metaplastic epithelium</title>
            <list list-type="order">
              <list-item>
                <p>Follicular Adenoma and variants.</p>
              </list-item>
              <list-item>
                <p>Follicular Carcinoma – Minimally invasive, widely invasive.</p>
              </list-item>
              <list-item>
                <p>Papillary Carcinoma and variants.</p>
              </list-item>
              <list-item>
                <p>Poorly differentiated thyroid Carcinoma including Insular Carcinoma </p>
              </list-item>
              <list-item>
                <p>Undifferentiated [anaplastic] and Squamous cell Carcinoma including Carcinosarcoma.</p>
              </list-item>
              <list-item>
                <p>Columnar cell Carcinoma.</p>
              </list-item>
              <list-item>
                <p>Mucoepidermoid Carcinoma.</p>
              </list-item>
              <list-item>
                <p>Sclerosing Mucoeidermoid Carcinoma with eosinophils.</p>
              </list-item>
              <list-item>
                <p>Mucinous Carcinoma.</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_4">
            <title>Tumors showing ‘C’ cell differentiation</title>
            <list list-type="order">
              <list-item>
                <p>Medullary Carcinoma and variants.</p>
              </list-item>
              <list-item>
                <p>‘C’ cell Adenoma.</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_5">
            <title>Tumors showing both Follicular and ‘C’ cell differentiation</title>
            <list list-type="order">
              <list-item>
                <p>Collision tumor Follicular/Papillary and Medullary Carcinoma.</p>
              </list-item>
              <list-item>
                <p>Mixed Follicular – paraFollicular Carcinoma.</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_6">
            <title>Tumors showing thymic or related branchial pouch differentiation</title>
            <list list-type="order">
              <list-item>
                <p>Ectopic thymoma.</p>
              </list-item>
              <list-item>
                <p>Spindle epithelial tumour with thymic like differentiation [SETTLE] [Intra thyroid spindle cell tumor with mucus cysts].</p>
              </list-item>
              <list-item>
                <p>Carcinoma showing thymic like differentiation [CASTLE so called intrathyroid epithelial thymoma.]</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_7">
            <title>Tumors of lymphoid cells</title>
            <list list-type="bullet">
              <list-item>
                <p>Malignant Lymphoma</p>
              </list-item>
              <list-item>
                <p>Plasmacytoma.</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_8">
            <title>Mesenchymal and other lesions</title>
            <list list-type="bullet">
              <list-item>
                <p>Benign and malignant mesenchymal tumors including angiosarcoma.</p>
              </list-item>
              <list-item>
                <p>Paraganglioma.</p>
              </list-item>
              <list-item>
                <p>Teratoma.[22]</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_9">
            <title>WHO Histological Classification of Thyroid Tumors</title>
          </sec>
          <sec id="sec-1_1_3_10">
            <title>Thyroid Carcinomas</title>
            <list list-type="bullet">
              <list-item>
                <p>Papillary Carcinoma</p>
              </list-item>
              <list-item>
                <p>Follicular Carcinoma</p>
              </list-item>
              <list-item>
                <p>Poorly differentiated Carcinoma</p>
              </list-item>
              <list-item>
                <p>Undifferentiated (anaplastic) Carcinoma</p>
              </list-item>
              <list-item>
                <p>Squamous cell Carcinoma</p>
              </list-item>
              <list-item>
                <p>Mucoepidermoid Carcinoma</p>
              </list-item>
              <list-item>
                <p>Sclerosing Mucoepidermoid Carcinoma with eosinophilia</p>
              </list-item>
              <list-item>
                <p>Mucinous Carcinoma</p>
              </list-item>
              <list-item>
                <p>Medullary Carcinoma</p>
              </list-item>
              <list-item>
                <p>Medullary Carcinoma</p>
              </list-item>
              <list-item>
                <p>Mixed Medullary and Follicular cell Carcinoma</p>
              </list-item>
              <list-item>
                <p>Spindle cell tumour with thymus-like differentiation</p>
              </list-item>
              <list-item>
                <p>Carcinoma showing Thymus-like differentiation [23]</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_11">
            <title>Thyroid Adenoma and related tumors</title>
            <list list-type="order">
              <list-item>
                <p>Follicular Adenoma</p>
              </list-item>
              <list-item>
                <p>Hyalinizing trabecular tumour</p>
              </list-item>
            </list>
          </sec>
          <sec id="sec-1_1_3_12">
            <title>Other Thyroid tumours</title>
            <list list-type="order">
              <list-item>
                <p>Teratoma</p>
              </list-item>
              <list-item>
                <p>Primary Lymphoma and Plasmacytoma</p>
              </list-item>
              <list-item>
                <p>Ectopic Thymoma</p>
              </list-item>
              <list-item>
                <p>Angiosarcoma</p>
              </list-item>
              <list-item>
                <p>Smooth muscle tumors</p>
              </list-item>
              <list-item>
                <p>Peripheral nerve sheath tumors</p>
              </list-item>
              <list-item>
                <p>Paraganglioma</p>
              </list-item>
              <list-item>
                <p>Solitary fibrous tumour</p>
              </list-item>
              <list-item>
                <p>Follicular dendritic cell tumour</p>
              </list-item>
              <list-item>
                <p>Langerhans cell histiocytosis</p>
              </list-item>
              <list-item>
                <p>Secondary tumours[24]</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="sec-1_1_4">
          <title>AIM</title>
          <p>A prospective work aimed to study the spectrum of cytological features of thyroid lesions in patients with thyroid swellings and to correlate the histological appearances where ever tissues were available in patients, who attended the Govt General Hospital, Vijayawada </p>
        </sec>
        <sec id="sec-1_1_5">
          <title>OBJECTIVES</title>
          <list list-type="bullet">
            <list-item>
              <p>To demonstrate the utility and limitations of aspiration cytology in thyroid lesions.</p>
            </list-item>
            <list-item>
              <p>To prove the importance of FNAC as the first line diagnostic procedure for the evaluation of goiter.</p>
            </list-item>
            <list-item>
              <p>To confirm its utility as a screening   procedure for selecting cases to surgery   </p>
            </list-item>
            <list-item>
              <p>To study the scope of FNAC in differentiating neoplastic from non neoplastic lesions </p>
            </list-item>
            <list-item>
              <p>To study its role as a diagnostic tool in picking up unsuspected malignancies and metastatic malignancies </p>
            </list-item>
          </list>
        </sec>
        <sec id="sec-1_1_6">
          <title>MATERIAL AND METHODS</title>
          <p>This  study  was  conducted  in  the department of  Pathology ,on patients with thyroid  swellings who attended the Medical, Surgical &amp;  ENT OPs  Rajiv Gandhi Institute of Medical sciences, a south Indian tertiary care teaching Government hospital Kadapa during  the period of July 2015 to November 2017. A total number of 375 aspirations were performed on patients with thyroid swellings, both male and female, who attended Medical, Surgical &amp;   ENT OPs during the above period. Smears prepared were stained with H&amp;E. Among the 375 cases aspirated   material obtained was sufficient for diagnosis in 330 cases. Remaining 45 cases showed only blood cellular elements and occasional thyroid acinar cells. Before proceeding to  FNAC  full clinical  examination of the patient was done  and  data like  present,  past and  personal  history  of  the patient  along  with  laboratory investigations  including  thyroid  profile  and  ultrasound  reports  were  collected. FNAC was done as an outpatient procedure. A 23-24 gauge needle was used for aspiration. No local anesthetic was used. Spirit swab, 10ml disposable syringe with 23-24 gauge needles, sclean glass slides, Fixative [methanol] used for aspiration procedure. The contents were expelled on to the labelled slides and smears were prepared. The slides were placed in the fixative for 20 minutes and stained. The numbers of aspirations made were 2-4 in each case. In a diffusely enlarged thyroid both the lobes were aspirated. In a Nodular goiter multiple aspirations were made. The stain used in the present study was H&amp;E. According to  Hamberger et al  in the assessment of a dominant nodule  6 clusters  of benign cells  in at least  2 slides  prepared from separate aspirates  constitute a reasonable minimum material for  diagnosing benign lesions. For the present study criteria of  Hamberger and  Orell were taken into consideration in case of dominant  nodule   and colloid goiter .For the diagnosis of  inflammatory and malignant  lesions , type of inflammatory cells  along with the back ground and cellular  features were taken into consideration  ,irrespective of  the amount of  cellularity. Basing on the above criteria the lesions aspirated were categorized as Benign, Malignant and Inadequate.</p>
        </sec>
        <sec id="sec-1_1_7">
          <title>RESULTS</title>
          <p>Out of the 330 cases diagnosed, majority were non neoplastic lesions (276) neoplastic were (54) [315]. Nodular goiter was found to be the commonest among all the lesions with 106 cases [32%] showing high prevalence between 21-30yrs and a male to female ratio of 1:8.7. Clinical presentation   in most of the cases was Multi Nodular goiter involving both the lobes. In a small fraction of cases [15%] it presented as solitary nodule. Association of Nodular goiter with Hashimoto’s thyroiditis was found in two cases and in one case Papillary Carcinoma. </p>
          <p>27 cases of Adenomatous hyperplasia were diagnosed of which 26 were females. Solitary nodular presentation was found in 22 %{ 6} cases. Common age group affected were 41- 50yrs.  Cases of simple goiter diagnosed were 25, all in women, with a peak incidence in 21-30yrs.</p>
          <p>15 cases of cystic lesions were diagnosed, mostly in the 31-40yrs age group with a female preponderance [12 females and 3 males].</p>
          <p>Thyroiditis cases which were 94 presented as diffuse swellings involving the entire gland in the 2<sup>nd</sup> to 5<sup>th</sup> decade. Lymphocytic thyroiditis was diagnosed in 30 cases of which 2 were males. All the cases of Hashimotos thyroiditis [59] and granulomatous thyroiditis [5] were diagnosed in middle aged women.</p>
          <p>39 cases were diagnosed as Follicular neoplasms, of these 34 were females and 5 were males. Clinical presentations of all these Follicular neoplasms were solitary nodules. They were commonly diagnosed in the 3rd to 4<sup>th</sup> decades. Malignant neoplasms comprised 15 cases, Papillary Carcinoma accounting for 13 cases [86.67%] and the remaining two were Medullary Carcinoma and Anaplastic Carcinoma [13.33%]</p>
          <p>Most of the Papillary Carcinomas were diagnosed in the 2<sup>nd</sup> -3<sup>rd</sup> decade and the female to male ratio was 3:1. Both the Medullary and Anaplastic Carcinomas were diagnosed in the 40-50yrs age group and in males. Surgical excision was done in 58 cases. Out of these, 26 patients with cytological diagnosis of Nodular goiter showed consistent picture in 17 cases. The remaining 11 cases were inconsistent. 6 cases were Follicular Adenomas, 2 cases were Papillary Carcinomas and 1 case of Thyrotoxicosis.</p>
          <p>5 Cases diagnosed as cystic lesions were biopsied, 4 cases showed consistent picture (2 cases of thyroglossal cyst &amp; 2 cases of infected cyst) and one case showed Nodular goiter. 18 cases diagnosed as Follicular neoplasms were subjected to histopathological examination. 12 cases showed Follicular Adenoma and two cases showed Follicular Carcinoma. The remaining 4 cases were hyperplastic lesions of MNG. 4 Cases of Papillary Carcinoma, 1 case of Anaplastic Carcinoma and 1 case of Medullary Carcinoma were excised and the histopathology was consistent in all the cases. 3 Cases were reported as inadequate on FNAC but after excision showed Follicular Adenomas.</p>
          <p>As follicular carcinomas cannot be differentiated from follicular adenomas on cytology we considered 12 cases of follicular adenoma and two cases of follicular carcinoma as true positive. These 14 cases of follicular neoplasms, 4 cases of papillary carcinomas, one case of medullary carcinoma and one case of anaplastic carcinoma were considered as true positive (total20). 4 cases of MNG which were diagnosed as follicular neoplasms on cytology were considered as false positive. 2 cases of papillary carcinoma and 6 cases of follicular adenoma which were diagnosed as nodular goiter on cytology were considered as false negative. </p>
          <p>The 18 cases of nodular goiter on FNAC ( excluding 2 cases of papillary carcinoma and 6 cases of follicular adenoma) and five cases of cystic lesions were found to be non neoplastic on histopathology and were considered as true negative.</p>
          <p>
            <bold>Table 2. Showing distribution of </bold>
            <bold>neoplastic &amp; non neoplastic cases</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No</bold>
                </td>
                <td>
                  <bold>Item</bold>
                </td>
                <td>
                  <bold>Number</bold>
                </td>
                <td>
                  <bold>Percentage</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Non neoplastic  lesions</td>
                <td>276</td>
                <td>83.64 %</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Neoplastic</td>
                <td>54</td>
                <td>16.36 %</td>
              </tr>
              <tr>
                <td colspan="4">Ratio of  non neoplastic to neoplastic  lesions is 5:1</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Table 3. Showing details of FNAC</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No</bold>
                </td>
                <td>
                  <bold>Item</bold>
                </td>
                <td>
                  <bold>Number</bold>
                </td>
                <td>
                  <bold>Percentage</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Adequate  for reporting</td>
                <td>330</td>
                <td>88 %</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Inadequate for reporting</td>
                <td>45</td>
                <td>12 %</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Total aspirations done</td>
                <td>375</td>
                <td>100 %</td>
              </tr>
              <tr>
                <td colspan="4">Percentage of adequacy 88%</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Table 4. showing the lesions  diagnosed on FNAC</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No</bold>
                </td>
                <td>
                  <bold>Type of Lesion</bold>
                </td>
                <td>
                  <bold>No of cases</bold>
                </td>
                <td>
                  <bold>Percentage</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>106</td>
                <td>32.11%</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Nodular goitre with hyperplasia</td>
                <td>27</td>
                <td>8.18%</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Simple goiter</td>
                <td>25</td>
                <td>7.58%</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Cystic lesions</td>
                <td>15</td>
                <td>4.55%</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Thyrotoxicosis</td>
                <td>9</td>
                <td>2.73%</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Lymphocytic thyroiditis</td>
                <td>30</td>
                <td>9.09%</td>
              </tr>
              <tr>
                <td>7</td>
                <td>Hashimoto’s thyroiditis</td>
                <td>59</td>
                <td>17.88%</td>
              </tr>
              <tr>
                <td>8</td>
                <td>Granulomatous thyroiditis</td>
                <td>5</td>
                <td>1.52%</td>
              </tr>
              <tr>
                <td>9</td>
                <td>Follicular neoplasm</td>
                <td>39</td>
                <td>11.82%</td>
              </tr>
              <tr>
                <td>10</td>
                <td>Papillary Carcinoma</td>
                <td>13</td>
                <td>3.94%</td>
              </tr>
              <tr>
                <td>11</td>
                <td>Medullary Carcinoma</td>
                <td>1</td>
                <td>0.30%</td>
              </tr>
              <tr>
                <td>12</td>
                <td>Anaplastic Carcinoma</td>
                <td>1</td>
                <td>0.30%</td>
              </tr>
              <tr>
                <td colspan="2">Total</td>
                <td>330</td>
                <td>100%</td>
              </tr>
            </table>
          </table-wrap>
          <fig>
            <graphic mimetype="image" xlink:href="image2.emf"/>
          </fig>
          <p>
            <bold>Figure 1. Chart showing distribution of lesions</bold>
          </p>
          <p>
            <bold>Table 5. Showing age wise distribution of cases</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td rowspan="2">
                  <bold>Sl.No</bold>
                </td>
                <td rowspan="2">
                  <bold>Type of Lesion</bold>
                </td>
                <td colspan="7">Age in years</td>
                <td rowspan="2">
                  <bold>Total</bold>
                </td>
              </tr>
              <tr>
                <td/>
                <td/>
                <td>
                  <bold>1-10</bold>
                </td>
                <td>
                  <bold>11-20</bold>
                </td>
                <td>
                  <bold>21-30</bold>
                </td>
                <td>
                  <bold>31-40</bold>
                </td>
                <td>
                  <bold>41-50</bold>
                </td>
                <td>
                  <bold>51-60</bold>
                </td>
                <td>
                  <bold>61-70</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>1</td>
                <td>8</td>
                <td>37</td>
                <td>34</td>
                <td>14</td>
                <td>8</td>
                <td>4</td>
                <td>106</td>
              </tr>
              <tr>
                <td>2</td>
                <td>NG with hyperplasia</td>
                <td/>
                <td>2</td>
                <td>8</td>
                <td>6</td>
                <td>9</td>
                <td>1</td>
                <td>1</td>
                <td>27</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Simple goiter</td>
                <td/>
                <td>4</td>
                <td>11</td>
                <td>6</td>
                <td>3</td>
                <td/>
                <td>1</td>
                <td>25</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Cystic lesions</td>
                <td/>
                <td>2</td>
                <td>1</td>
                <td>6</td>
                <td>3</td>
                <td>2</td>
                <td>1</td>
                <td>15</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Thyrotoxicosis</td>
                <td/>
                <td>1</td>
                <td>2</td>
                <td>3</td>
                <td>2</td>
                <td/>
                <td>1</td>
                <td>9</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Lymph thyroiditis</td>
                <td/>
                <td>8</td>
                <td>7</td>
                <td>10</td>
                <td>5</td>
                <td/>
                <td/>
                <td>30</td>
              </tr>
              <tr>
                <td>7</td>
                <td>Hashi thyroiditis</td>
                <td/>
                <td>12</td>
                <td>18</td>
                <td>22</td>
                <td>4</td>
                <td>3</td>
                <td/>
                <td>59</td>
              </tr>
              <tr>
                <td>8</td>
                <td>Granulo thyroiditis</td>
                <td/>
                <td/>
                <td>2</td>
                <td>3</td>
                <td/>
                <td/>
                <td/>
                <td>5</td>
              </tr>
              <tr>
                <td>9</td>
                <td>Follicular neoplasm</td>
                <td/>
                <td>4</td>
                <td>15</td>
                <td>10</td>
                <td>5</td>
                <td>5</td>
                <td/>
                <td>39</td>
              </tr>
              <tr>
                <td>10</td>
                <td>Papillary Carcinoma</td>
                <td/>
                <td/>
                <td>7</td>
                <td>3</td>
                <td>1</td>
                <td>2</td>
                <td/>
                <td>13</td>
              </tr>
              <tr>
                <td>11</td>
                <td>Medullary Carcinoma</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td>1</td>
                <td/>
                <td/>
                <td>1</td>
              </tr>
              <tr>
                <td>12</td>
                <td>Anaplastic Carcinoma</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td>1</td>
                <td/>
                <td/>
                <td>1</td>
              </tr>
              <tr>
                <td>13</td>
                <td>Inadequate</td>
                <td>2</td>
                <td>4</td>
                <td>13</td>
                <td>12</td>
                <td>11</td>
                <td>1</td>
                <td>2</td>
                <td>45</td>
              </tr>
              <tr>
                <td colspan="2">
                  <bold>Total</bold>
                </td>
                <td>
                  <bold>3</bold>
                </td>
                <td>
                  <bold>45</bold>
                </td>
                <td>
                  <bold>121</bold>
                </td>
                <td>
                  <bold>115</bold>
                </td>
                <td>
                  <bold>59</bold>
                </td>
                <td>
                  <bold>23</bold>
                </td>
                <td>
                  <bold>10</bold>
                </td>
                <td>
                  <bold>375</bold>
                </td>
              </tr>
              <tr>
                <td colspan="10">Commonest age group affected is between 21-30 yrs</td>
              </tr>
            </table>
          </table-wrap>
          <fig>
            <graphic mimetype="image" xlink:href="image3.emf"/>
          </fig>
          <p>
            <bold>Figure 2. Chart showing age wise distribution of cases in the study</bold>
          </p>
          <p>
            <bold>Table  6. showing common affected age group</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No</bold>
                </td>
                <td>
                  <bold>Type of Lesion</bold>
                </td>
                <td>
                  <bold>Age group</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>21-30</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Nodular goitre with hyperplasia</td>
                <td>41-50</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Simple goiter</td>
                <td>21-30</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Cystic lesions</td>
                <td>31-40</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Thyrotoxicosis</td>
                <td>31-40</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Lymphocytic thyroiditis</td>
                <td>31-40</td>
              </tr>
              <tr>
                <td>7</td>
                <td>Hashimoto’s thyroiditis</td>
                <td>31-40</td>
              </tr>
              <tr>
                <td>8</td>
                <td>Granulomatous thyroiditis</td>
                <td>31-40</td>
              </tr>
              <tr>
                <td>9</td>
                <td>Follicular neoplasm</td>
                <td>21-30</td>
              </tr>
              <tr>
                <td>10</td>
                <td>Papillary Carcinoma</td>
                <td>21-40</td>
              </tr>
              <tr>
                <td>11</td>
                <td>Medullary Carcinoma</td>
                <td>41-50</td>
              </tr>
              <tr>
                <td>12</td>
                <td>Anaplastic Carcinoma</td>
                <td>51-60</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Table 7. Showing sex wise distribution of cases</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No.</bold>
                </td>
                <td>
                  <bold>Type of Lesion</bold>
                </td>
                <td>
                  <bold>Females</bold>
                </td>
                <td>
                  <bold>Males</bold>
                </td>
                <td>
                  <bold>Total No. Cases</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>95</td>
                <td>11</td>
                <td>106</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Nodular goitre with hyperplasia</td>
                <td>26</td>
                <td>1</td>
                <td>27</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Simple goiter</td>
                <td>25</td>
                <td>0</td>
                <td>25</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Cystic lesions</td>
                <td>12</td>
                <td>3</td>
                <td>15</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Thyrotoxicosis</td>
                <td>6</td>
                <td>3</td>
                <td>9</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Lymphocytic thyroiditis</td>
                <td>28</td>
                <td>2</td>
                <td>30</td>
              </tr>
              <tr>
                <td>7</td>
                <td>Hashimoto’s thyroiditis</td>
                <td>59</td>
                <td>0</td>
                <td>59</td>
              </tr>
              <tr>
                <td>8</td>
                <td>Granulomatous thyroiditis</td>
                <td>5</td>
                <td>0</td>
                <td>5</td>
              </tr>
              <tr>
                <td>9</td>
                <td>Follicular neoplasm</td>
                <td>34</td>
                <td>5</td>
                <td>39</td>
              </tr>
              <tr>
                <td>10</td>
                <td>Papillary Carcinoma</td>
                <td>10</td>
                <td>3</td>
                <td>13</td>
              </tr>
              <tr>
                <td>11</td>
                <td>Medullary Carcinoma</td>
                <td>0</td>
                <td>1</td>
                <td>1</td>
              </tr>
              <tr>
                <td>12</td>
                <td>Anaplastic Carcinoma</td>
                <td>0</td>
                <td>1</td>
                <td>1</td>
              </tr>
              <tr>
                <td>13</td>
                <td>Inadequate</td>
                <td>41</td>
                <td>4</td>
                <td>45</td>
              </tr>
              <tr>
                <td colspan="2">Total</td>
                <td>341</td>
                <td>34</td>
                <td>375</td>
              </tr>
              <tr>
                <td colspan="5">Female to male ratio of thyroid lesions is 10 : 1Female to male ratio of among neoplastic lesions is 4.4 : 1</td>
              </tr>
            </table>
          </table-wrap>
          <fig>
            <graphic mimetype="image" xlink:href="image4.emf"/>
          </fig>
          <p>
            <bold>Figure 3. Chart showing sex wise </bold>
            <bold>distribution of cases in the study</bold>
          </p>
          <p>
            <bold>Table 8. Showing lesions with solitary nodular presentation</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No.</bold>
                </td>
                <td>
                  <bold>Lesion</bold>
                </td>
                <td>
                  <bold>No of cases</bold>
                </td>
                <td>
                  <bold>%</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>11</td>
                <td>18.33</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Nodular goitre with hyperplasia</td>
                <td>6</td>
                <td>10</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Cystic lesion</td>
                <td>2</td>
                <td>3.33</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Follicular neoplasm</td>
                <td>39</td>
                <td>65</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Papillary Carcinoma</td>
                <td>2</td>
                <td>3.33</td>
              </tr>
              <tr>
                <td colspan="2">Total</td>
                <td>60</td>
                <td>100%</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Table 9.  Showing percentage of non neoplastic lesions</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No.</bold>
                </td>
                <td>
                  <bold>Lesion</bold>
                </td>
                <td>
                  <bold>No of cases</bold>
                </td>
                <td>
                  <bold>%</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>106</td>
                <td>38.41</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Nodular goitre with hyperplasia</td>
                <td>27</td>
                <td>9.78</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Simple goiter</td>
                <td>25</td>
                <td>9.06</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Cystic lesions</td>
                <td>15</td>
                <td>5.43</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Thyrotoxicosis</td>
                <td>9</td>
                <td>3.26</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Lymphocytic thyroiditis</td>
                <td>30</td>
                <td>10.87</td>
              </tr>
              <tr>
                <td>7</td>
                <td>Hashimoto’s thyroiditis</td>
                <td>59</td>
                <td>21.38</td>
              </tr>
              <tr>
                <td>8</td>
                <td>Granulomatous thyroiditis</td>
                <td>5</td>
                <td>1.81</td>
              </tr>
              <tr>
                <td colspan="2">Total</td>
                <td>276</td>
                <td>100%</td>
              </tr>
              <tr>
                <td colspan="4">Nodular goitre is the commonest  lesion</td>
              </tr>
            </table>
          </table-wrap>
          <fig>
            <graphic mimetype="image" xlink:href="image5.emf"/>
          </fig>
          <p>
            <bold>Figure 4. Chart showing distribution of non neoplastic</bold>
            <bold> lesions</bold>
          </p>
          <p>
            <bold>Table  10. Showing percentage of neoplastic lesions</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No.</bold>
                </td>
                <td>
                  <bold>Name of tumor</bold>
                </td>
                <td>
                  <bold>No of cases</bold>
                </td>
                <td>
                  <bold>%</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Follicular neoplasm</td>
                <td>39</td>
                <td>72.22</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Papillary Carcinoma</td>
                <td>13</td>
                <td>24.08</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Medullary Carcinoma</td>
                <td>1</td>
                <td>1.85</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Anaplastic Carcinoma</td>
                <td>1</td>
                <td>1.85</td>
              </tr>
              <tr>
                <td colspan="2">Total</td>
                <td>54</td>
                <td>100%</td>
              </tr>
            </table>
          </table-wrap>
          <fig>
            <graphic mimetype="image" xlink:href="image6.emf"/>
          </fig>
          <p>
            <bold>Figure 5.</bold>
            <bold> Chart showing distribution of neoplastic lesions</bold>
          </p>
          <p>
            <bold>Table 11. Showing number of cases subjected to HPE</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No.</bold>
                </td>
                <td>
                  <bold>Lesion </bold>
                </td>
                <td>
                  <bold>No of  cases</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goiter</td>
                <td>26</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Cystic lesion</td>
                <td>5</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Follicular neoplasm</td>
                <td>18</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Papillary Carcinoma</td>
                <td>4</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Anaplastic Carcinoma</td>
                <td>1</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Medullary Carcinoma</td>
                <td>1</td>
              </tr>
              <tr>
                <td/>
                <td>TOTAL</td>
                <td>55</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Table  12. Showing Cytological Vs histopathological correlations</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td rowspan="2">
                  <bold>Cytological diagnosis</bold>
                </td>
                <td colspan="9">
                  <bold>Histopathological diagnosis</bold>
                </td>
              </tr>
              <tr>
                <td/>
                <td>Nodular goitre</td>
                <td>Cystic lesion</td>
                <td>Follicular Adenoma</td>
                <td>Follicular Carcinoma</td>
                <td>Papillary Carcinoma</td>
                <td>Anaplas Carcinoma</td>
                <td>Medullary Carcinoma</td>
                <td>Toxicosis</td>
                <td>Total</td>
              </tr>
              <tr>
                <td>Nodular goiter</td>
                <td>17</td>
                <td>0</td>
                <td>6</td>
                <td>0</td>
                <td>2</td>
                <td>0</td>
                <td>0</td>
                <td>1</td>
                <td>26</td>
              </tr>
              <tr>
                <td>Cystic lesion</td>
                <td>1</td>
                <td>4</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>5</td>
              </tr>
              <tr>
                <td>Follicular neoplasm</td>
                <td>4</td>
                <td>0</td>
                <td>12</td>
                <td>2</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>18</td>
              </tr>
              <tr>
                <td>Papillary Carcinoma</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>4</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>4</td>
              </tr>
              <tr>
                <td>Anaplastic Carcinoma</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>1</td>
                <td>0</td>
                <td>0</td>
                <td>1</td>
              </tr>
              <tr>
                <td>Medullary Carcinoma</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>0</td>
                <td>1</td>
                <td>0</td>
                <td>1</td>
              </tr>
              <tr>
                <td>Total</td>
                <td>22</td>
                <td>4</td>
                <td>18</td>
                <td>2</td>
                <td>6</td>
                <td>1</td>
                <td>1</td>
                <td>1</td>
                <td>55</td>
              </tr>
            </table>
          </table-wrap>
          <p>
            <bold>Table 13. Showing Histopathological correlation</bold>
          </p>
          <table-wrap>
            <table>
              <tr>
                <td>
                  <bold>Sl.No.</bold>
                </td>
                <td>
                  <bold>Type of lesion</bold>
                </td>
                <td>
                  <bold>Diagnosed </bold>
                  <bold>on FNAC</bold>
                </td>
                <td>
                  <bold>Biopsy </bold>
                  <bold>correlation</bold>
                </td>
                <td>
                  <bold>% of</bold>
                  <bold> correlation</bold>
                </td>
              </tr>
              <tr>
                <td>1</td>
                <td>Nodular goitre</td>
                <td>26</td>
                <td>17</td>
                <td>65.83</td>
              </tr>
              <tr>
                <td>2</td>
                <td>Cystic lesion</td>
                <td>5</td>
                <td>4</td>
                <td>80</td>
              </tr>
              <tr>
                <td>3</td>
                <td>Follicular neoplasm</td>
                <td>18</td>
                <td>14</td>
                <td>77.78</td>
              </tr>
              <tr>
                <td>4</td>
                <td>Papillary Carcinoma</td>
                <td>4</td>
                <td>4</td>
                <td>100</td>
              </tr>
              <tr>
                <td>5</td>
                <td>Anaplastic Carcinoma</td>
                <td>1</td>
                <td>1</td>
                <td>100</td>
              </tr>
              <tr>
                <td>6</td>
                <td>Medullary Carcinoma</td>
                <td>1</td>
                <td>1</td>
                <td>100</td>
              </tr>
            </table>
          </table-wrap>
          <sec id="sec-1_1_7_1"/>
          <sec id="sec-1_1_7_2">
            <title>Statistical analysis of correlation   </title>
            <p>True positive =20, True negative =23, False positive=4, False negative=8</p>
            <p>
              <bold>Table 14. Showing Statistical Analysis</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td rowspan="2">
                    <bold>Cytology</bold>
                  </td>
                  <td colspan="2">
                    <bold>Histology</bold>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td>
                    <bold>Non neoplastic</bold>
                  </td>
                  <td>
                    <bold>Neoplastic</bold>
                  </td>
                </tr>
                <tr>
                  <td>Non neoplastic</td>
                  <td>TN 23</td>
                  <td>FN 8</td>
                </tr>
                <tr>
                  <td>Neoplastic</td>
                  <td>FP 4</td>
                  <td>TP 20</td>
                </tr>
                <tr>
                  <td colspan="3">Sensitivity=TP X100/TP+FN   =71.42%Specificity=TNX100/TN+FP=85.19%Positive predictive value=TPX100/TP+FP=83.33%Negative predictive value=TN X100/TN+FN=74.20%False positive ratio= FPX100/ FP+TN=14.81%False negative ratio=FNX100/FN+TP=28.57%Accuracy=TP+TNX100/TP+TN+FP+FN=78.18%</td>
                </tr>
              </table>
            </table-wrap>
            <p>
              <bold>Table15. Showing statistical comparision</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>Study</bold>
                  </td>
                  <td>
                    <bold>FNAC</bold>
                  </td>
                  <td>
                    <bold>Histopath</bold>
                  </td>
                  <td>
                    <bold>Sensitivity</bold>
                  </td>
                  <td>
                    <bold>Specificity</bold>
                  </td>
                  <td>
                    <bold>PPV</bold>
                  </td>
                  <td>
                    <bold>NPV </bold>
                  </td>
                  <td>
                    <bold>Insufficient</bold>
                  </td>
                  <td>
                    <bold>Accuracy</bold>
                  </td>
                </tr>
                <tr>
                  <td>Kendrel</td>
                  <td>113</td>
                  <td>34</td>
                  <td>-</td>
                  <td>-</td>
                  <td>-</td>
                  <td>-</td>
                  <td>6%</td>
                  <td>-</td>
                </tr>
                <tr>
                  <td>Piromali et al</td>
                  <td>795</td>
                  <td>216</td>
                  <td>95%</td>
                  <td>98%</td>
                  <td>95%</td>
                  <td>97%</td>
                  <td>-</td>
                  <td>-</td>
                </tr>
                <tr>
                  <td>Godinho matos et al</td>
                  <td>144</td>
                  <td>28</td>
                  <td>73%</td>
                  <td>100%</td>
                  <td>100%</td>
                  <td>69%</td>
                  <td>13%</td>
                  <td>83%</td>
                </tr>
                <tr>
                  <td>Mandrekar et al</td>
                  <td>1992</td>
                  <td>238</td>
                  <td>53%</td>
                  <td>93%</td>
                  <td>82%</td>
                  <td>78%</td>
                  <td>12%</td>
                  <td>79%</td>
                </tr>
                <tr>
                  <td>Holemm et al</td>
                  <td>112</td>
                  <td>53</td>
                  <td>84%</td>
                  <td>52%</td>
                  <td>53%</td>
                  <td>83%</td>
                  <td>11%</td>
                  <td>65%</td>
                </tr>
                <tr>
                  <td>Burch et al</td>
                  <td>504</td>
                  <td>-</td>
                  <td>80%</td>
                  <td>73%</td>
                  <td>-</td>
                  <td>-</td>
                  <td>-</td>
                  <td>75%</td>
                </tr>
                <tr>
                  <td>Leonard &amp; Melcher</td>
                  <td>335</td>
                  <td>187</td>
                  <td>88%</td>
                  <td>78%</td>
                  <td>46%</td>
                  <td>97%</td>
                  <td>18%</td>
                  <td>80%</td>
                </tr>
                <tr>
                  <td>Present</td>
                  <td>375</td>
                  <td>55</td>
                  <td>71.4%</td>
                  <td>85.2%</td>
                  <td>83.3%</td>
                  <td>74.2</td>
                  <td>12%</td>
                  <td>78.2%</td>
                </tr>
              </table>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sec-1_1_8"/>
        <sec id="sec-1_1_9">
          <title>DISCUSSION</title>
          <p>Thyroid swellings are very common and can occur in various clinical settings and in various age groups [25].The modalities of treatment differ in different conditions. Some require therapeutic management and some others surgery. FNAC was proved to be the single most sensitive investigation in differentiating neoplastic from non- neoplastic conditions, and benign from malignant conditions [26,27]. At present this procedure is utilized extensively in diagnosing the condition and planning for surgery in necessary cases thus decreasing the unnecessary surgeries [28].</p>
          <p>In the present study FNAC of Thyroid was done in 375 cases. Material sufficient for reporting was obtained in 330 cases [88%] and 45 cases [12 %] were inadequate showing only blood cellular elements and occasional thyroid acinar cells. The rate of inadequacy ranged from 9-31% according to various publications. Various factors are responsible for getting inadequate material [29]. It depends on the experience of the aspirator, the size of the nodule, type of the nodule, number of aspirations and the duration of the aspiration [30]. Rate of inadequacy in our study was 12%.</p>
          <p>In our experience 23 and 24G needles yielded sufficient material. Material obtained was scanty with 25 G needle and was very hemorrhagic with 22G needle. Increased number of aspirations yielded more material when compared to a single aspiration for extended time. Aspirations from cases of thyrotoxicosis and certain Adenomas were very hemorrhagic. Non- aspiration technique described by Jayaram et al was used in these cases</p>
          <p>FNAC is safe, less expensive and of great patient compliance [31]. Piramol reported skin bruises in 3.3% of cases and Safinullah [32] recorded skin bruises and haematomas in 6% of cases ; So the  complication rate in our study was not  high.  We didn’t experience any major complications except in one case where the patient went into a shock like state, but recovered in a few minutes without any treatment. Minor complications like haematoma and skin bruises were observed in 3% of cases. </p>
          <p>In the large series of Mayo clinic [6300cases] benign diseases represented 65% of the total lesions which included benign goiters and thyroiditis.  In the series of Schenek benign diseases represented 83%.</p>
          <p>In the present study   benign non -neoplastic cases were 276 representing 80% of the total cases, so our results were almost the same with the other studies. </p>
        </sec>
        <sec id="sec-1_1_10">
          <title>CONCLUSIONS</title>
          <p>FNAC has been found to be a most valuable, economized, safe and simple diagnostic procedure in the evaluation of thyroid swellings. The present study was found to be very useful in differentiating Neoplastic from Non neoplatic thyroid lesions. The present study aided in the diagnosis of Malignant Thyroid lesions with great accuracy. The utility of FNAC as a screening procedure, in selecting patients for Surgery was satisfactory (No surgery was performed in cases of thyroiditis).</p>
        </sec>
        <sec id="sec-1_1_11">
          <title>REFERENCES</title>
          <list list-type="order">
            <list-item>
              <p>AG. Valand,Sushma ram raje,B S Pandeya, R Shedge. Anaplastic thyroid Carcinoma with osteoclast-like giant cells. JAPI 52, 2004, 585-586.</p>
            </list-item>
            <list-item>
              <p>Albores- Saavedra J. Gould E. Vardaman C.et al. The macroFollicular variant of Papillary thyroid cancer. A study of 17 cases.Hum  Pathol 22, 1991, 1195-205.</p>
            </list-item>
            <list-item>
              <p>Altavilla G, Pascale M,Nenci I; Fine needle aspiration  cytology of thyroid gland diseases; Acta cytol 34, 1990, 251-6</p>
            </list-item>
            <list-item>
              <p>Ananthan Krishnan N, Rao KM, Narasimhan R, Veliath AJ. Problems and limitations of fine needle aspiration cytology in solitary thyroid nodules. Aust. Nzl. Surg. 60[1], 1990, 35-9</p>
            </list-item>
            <list-item>
              <p>Anil; T. Ahuja ,  Ann D. King, Walter King Conmatreveli. Thyroglossal duct cysts; sonographic  appearance in adults  ; A. J. Neuro radiology 20, 579-582</p>
            </list-item>
            <list-item>
              <p>A.Ruter R.Nishiyama, S .Lenquisa; Tall cell variant of Papillary thyroid cancer; Disregarded entity; World journal of Surgery Spinger Newyork 21, 1997,15-21</p>
            </list-item>
            <list-item>
              <p>Asken LA. Livolci VA. Prognostic significance of  histological gradin g compared to Sub classification of Papillary thyroid  Carcinoma  Cancer 88, 2000, 1902-8</p>
            </list-item>
            <list-item>
              <p>Leopold G. Koss Diagnostic cytology 2, 1979.</p>
            </list-item>
            <list-item>
              <p>Berry B . Mac farlane J.  Chan N. Osteoclastoma like anaplastic Carcinoma of thyroid; diagnosis by fine needle aspiration cytology. Acta cytol 34[2], 1990, 248-50.</p>
            </list-item>
            <list-item>
              <p>Bhaskaran CS Kumar GH, Srinivas M, Kameswari R, RAO g, Aruna CA.  Fine needle aspiration cytology reviewof 1731 cases .Indian J Pathol. Microbio. 33[4], 1990, 387-97.</p>
            </list-item>
            <list-item>
              <p>Bose S Kapila K Verma K. Medullary Carcinoma of thyroid ; cytological , immunohistochemical and ultra structural study Diagn  cyto pathol 8[1], 1992, 28-32</p>
            </list-item>
            <list-item>
              <p>Bouvet M.  Fried man JI.  Surgical management of thyroid nodules; Paient selection based on the results of FNAC. Laryngoscope .102, 1353-1356</p>
            </list-item>
            <list-item>
              <p>Burch HB. Burman KD Reed hl.  Buchner l. Raber T. Owenbey JL . Fine needle aspiration cytology of thyroid nodules – Determinants of insufficiency rate and malignancy yield at thyroidectomy. Acta. cytol 40, 1996¸ 1176-83</p>
            </list-item>
            <list-item>
              <p>Carcangiu ML.Sibley RK. Rosai J. Clear cell change in primary thyroid tumors. A study of 38 cases Am. J Surg Pathol; 9, 1985, 705-22</p>
            </list-item>
            <list-item>
              <p>Choi, Kyung, Kim, Jee Yeon Park, Doyounlee. Recommendations for the management of cystic thyroid nodules . ANZ Jour. Surg. 75[7], 1998, 537-54</p>
            </list-item>
            <list-item>
              <p>Cusick E.; Mcintosh CA; KrukowskyZH; Matheson NA. Cystic change and neoplasia in isolated thyroid swellings. Br J  Surg 75[10], 1988, 982-3</p>
            </list-item>
            <list-item>
              <p>Dean DS, Hay ID. Prognostic indicators in differentiated thyroid Carcinoma. Cancer control. 7[3], 2000, 229-39</p>
            </list-item>
            <list-item>
              <p>18. Delos Santos S ,ET; Keihai R ofagha S, CunninghamJJ, Mazzaferri EL. Cystic thyroid  nodules –The dilemma of malignant lesions ; Arch Int   M ed 150[7], 1990, 1422-7</p>
            </list-item>
            <list-item>
              <p>Desai Saral;Sarkar ; Suchane; Borges Anita M ; A study of histopathologic features of  M edullary Carcinoma of thyroid . Casess from a single institute in India ;Indian journal of Cancer Year l 42, 2005, 25-29</p>
            </list-item>
            <list-item>
              <p>Emmanuel Rubin, Fred Gorstein. Rubins Pathology –Clinicopathological foundation of Medicine Saunders 2006</p>
            </list-item>
            <list-item>
              <p>Esmaili J H; Hafe GR;Warner TF; Anaplastic Carcinoma of thyroid with osteoclast like giant cells; Cancer 53, 1983, 2122-2125</p>
            </list-item>
            <list-item>
              <p>Ghazala Mehdi ;MD D.C.H, Hena.A, A nsari MD, Shahid Ali Siddiqui MD; Cytology of anaplastic giant cell Carcinoma of thyroid with osteoclast like giant cells – A case  report; Diagnostic cytopathology, l35(2), 111-112.</p>
            </list-item>
            <list-item>
              <p>Gharib H; GoellnerJ R; Johnson DA; Fine –needle aspiration cytology of the thyroid. A 12 year experience with 11,000 biopsies. Clin Lab Med 13[3], 1993, 699-709</p>
            </list-item>
            <list-item>
              <p>Godinho-matos L. Kock joh n G. Kurtz A. Contribution of FNAC in the diagnosis and management of thyroid disease. J. Cli. Path. 45, 1992, 391-5 </p>
            </list-item>
            <list-item>
              <p>GoelnerJR, Gharib H, Grant OS, Johnson DA; Fine needle cytology of the thyroid ,1980-1986; Acta cytol 31, 1987, 587-90</p>
            </list-item>
            <list-item>
              <p>Gold stein, Richard E, N efeville, J ames L. I mplications of Follicular neolasms, atypia, and lesions suspicious for malignancies diagnosed by fine needle aspiration of the thyroid nodule. Ann. Surgery; 235 [5]  656-664</p>
            </list-item>
            <list-item>
              <p>G P S  Yeah, KW Chan. The diagnostic value of fine needle aspiration cytology in the assessment of thyroid nodules; A retrospective 5 year analysis. H K M J ; 5, 1999, 140-4</p>
            </list-item>
            <list-item>
              <p>Gumhar aric ; Elif Pestereli ,Husane  Alitumbas; Anaplastic  thyroid cancer presenting with thyrotoxicosis and hyperactive thyroid nodule; Case report &amp; literature review</p>
            </list-item>
            <list-item>
              <p>Hammer M, Wortsman J, Foise L. Cancer in cystic lesions of the thyroid; Arch. Surg 117[8], 1982, 1020-3</p>
            </list-item>
            <list-item>
              <p>Harach HR, Zusman SB; Cytopathology of Tall cell variant of thyroid Papillary Carcinoma. Acta .cytol. 36[5], 1992, 895-99</p>
            </list-item>
            <list-item>
              <p>Haruna A, Nggada, Alhaji B, Musa, Bara M, Musthafa JA Khalil. Fine needle aspiration cytology of thyroid nodules; A Nigerian tertiary hospital experience The Int . jou. Of  cardiovascular  research .2006;5[1]</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </sec>
  </body>
  <back/>
</article>
